Your browser doesn't support javascript.
loading
Synthetic ligustrazine based cyclohexanone and oxime analogs as Anti-Trypanosoma and Anti-Leishmanial agentes
Alkhaldi, Abdulsalam A. M; Koning, Harry P. de; Bukhari, Syed Nasir Abbas.
  • Alkhaldi, Abdulsalam A. M; Jouf University. College of Science. Biology department. SA
  • Koning, Harry P. de; Institute of Infection, Immunity and Inflammation. College of Medical, Veterinary and Life Sciences. University of Glasgow. GB
  • Bukhari, Syed Nasir Abbas; Jouf University. College of Pharmacy. Department of Pharmaceutical Chemistry. SA
Braz. J. Pharm. Sci. (Online) ; 57: e18997, 2021. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1345455
ABSTRACT
In the present study a series of 34 synthetic ligustrazine-containing α, ß-Unsaturated carbonyl-based compounds and oximes, recognized as anticancer compounds were assessed against protozoa of the Trypanosoma and Leishmania species. Ligustrazine, chemically known as tetramethylpyrazine (TMP), was selected as the core moiety for the synthesis of α, ß-Unsaturated carbonyl-based compounds and these compounds were selected as precursors for the synthesis of new oximes. Some derivates, including 5f and 6i, showed multiple activities against all tested strains. In particular compounds 5f and 8o are the most potent and they are, therefore, potential candidates for trypanosomiasis and leishmaniasis
Asunto(s)


Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Oximas / Ciclohexanonas Idioma: Inglés Revista: Braz. J. Pharm. Sci. (Online) Asunto de la revista: Farmacologia / Terapˆutica / Toxicologia Año: 2021 Tipo del documento: Artículo País de afiliación: Arabia Saudita / Reino Unido Institución/País de afiliación: Institute of Infection, Immunity and Inflammation/GB / Jouf University/SA

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Oximas / Ciclohexanonas Idioma: Inglés Revista: Braz. J. Pharm. Sci. (Online) Asunto de la revista: Farmacologia / Terapˆutica / Toxicologia Año: 2021 Tipo del documento: Artículo País de afiliación: Arabia Saudita / Reino Unido Institución/País de afiliación: Institute of Infection, Immunity and Inflammation/GB / Jouf University/SA